Search research articles
Contact Us
Filters
Showing results (1-10 of 158) with videos related to
Page
of 16
Sort By:
Journal of Clinical Medicine
|
November 9, 2024
Bridging Gaps and Charting Future Directions in Vasculitis
Ryu Watanabe
Annals of the Rheumatic Diseases
|
April 29, 2020
JAK inhibitors as promising agents for refractory Takayasu arteritis
Ryu Watanabe
Journal of Bone and Mineral Metabolism
|
April 11, 2020
High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis
Ryu Watanabe
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 27, 2019
CD4+ T Cells as Key Players in the Immunopathology of Takayasu Arteritis: Comment on the Article by
Ryu Watanabe
International Journal of Cardiology
|
May 14, 2019
Challenging therapeutic goal in large vessel vasculitis: Comment on "Statins reduce relapse rate in Takayasu arteritis" published in the journal
Ryu Watanabe
Rheumatology (Oxford, England)
|
June 29, 2020
Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
Ryu Watanabe
Frontiers in Aging Neuroscience
|
May 2, 2022
Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders
Ryu Watanabe, Motomu Hashimoto
Annals of the Rheumatic Diseases
|
August 10, 2020
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
Ryu Watanabe, Motomu Hashimoto
Frontiers in Immunology
|
April 18, 2022
Perspectives of JAK Inhibitors for Large Vessel Vasculitis
Ryu Watanabe, Motomu Hashimoto
Rheumatology (Oxford, England)
|
February 15, 2022
Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis
Ryu Watanabe, Motomu Hashimoto
Page
of 16
Search research articles
Search
Showing results (1-10 of 158) with videos related to
Sort By:
Page
of 16
Journal of Clinical Medicine
|
November 9, 2024
Bridging Gaps and Charting Future Directions in Vasculitis
Ryu Watanabe
Annals of the Rheumatic Diseases
|
April 29, 2020
JAK inhibitors as promising agents for refractory Takayasu arteritis
Ryu Watanabe
Journal of Bone and Mineral Metabolism
|
April 11, 2020
High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis
Ryu Watanabe
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 27, 2019
CD4+ T Cells as Key Players in the Immunopathology of Takayasu Arteritis: Comment on the Article by
Ryu Watanabe
International Journal of Cardiology
|
May 14, 2019
Challenging therapeutic goal in large vessel vasculitis: Comment on "Statins reduce relapse rate in Takayasu arteritis" published in the journal
Ryu Watanabe
Rheumatology (Oxford, England)
|
June 29, 2020
Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
Ryu Watanabe
Frontiers in Aging Neuroscience
|
May 2, 2022
Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders
Ryu Watanabe, Motomu Hashimoto
Annals of the Rheumatic Diseases
|
August 10, 2020
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
Ryu Watanabe, Motomu Hashimoto
Frontiers in Immunology
|
April 18, 2022
Perspectives of JAK Inhibitors for Large Vessel Vasculitis
Ryu Watanabe, Motomu Hashimoto
Rheumatology (Oxford, England)
|
February 15, 2022
Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis
Ryu Watanabe, Motomu Hashimoto
Page
of 16